Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services

Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members

Round table discussion - PRECIOUS METALS

Latest Share Chat

PPC. Good for us an-
d PPC, IMO. A clean..

KLG. We all give in
(admitted or not) ..

ENRC. Strengthens K-
Z's balance sheet a..

SOLO. Shifts you co-
plete cretin. Most ..

SOLG. No disrepect,-
but any chance you ..

GBP. Volume and int-
erest in non existe..

SOLO. ox·y-
;mo·ron /&a..

SNRP. Metcalfe stil
have a holding her..

SOLO. You just post-
d 36 min after me!!..

XEN. OncoHist Ph I
trial (Ph I trials ..

Gw Pharmaceuticals Regulatory News (GWP)

Regulatory News for Gw Pharmaceuticals (GWP)

Share Price: 49.375

Bid: 49.00

Ask: 49.75

Change: 0.00 (0.00%)

Spread: 0.75

Spread as %: 1.53%

Open: 48.25

High: 49.95

Low: 48.25

Yesterday’s Close: 49.375

GWP Share News

GWP ShareCast

GWP Regulatory

Holding(s) in Company

Wed, 5th Oct 2011 14:51

RNS Number : 6275P

GW Pharmaceuticals PLC

05 October 2011


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ			GW Pharmaceuticals
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Change of custodian			X
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ		Prudential plc group of companies
4. Full name of shareholder(s) (if different from 3.):^iv		STATE STREET NOMS LTD A/C GMIQ
5. Date of the transaction and date on which the threshold is crossed or reached: ^v		3 October 2011
6. Date on which issuer notified:		4 October 2011
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}		See item 13

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Direct

Direct ^xi

Indirect ^xii

Direct

Indirect

GB0030544687

18,303,889

13.76%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

18,303,889

13.76%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi
Prudential plc (parent Company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited)

Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A

13. Additional information:	Following a change of custodian for a large number of funds managed by M&G, the registration details have changed and are now as detailed on the attached report. No other material changes have taken place
14. Contact name:	James Todd / Mark Thomas M&G Investment Management Limited
15. Contact telephone number:	020 7548 2293 / 020 7548 3266

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEADESESEFFFF

Related Shares: GW Pharmaceuticals (GWP).

Date	Source	Headline	Category
14-May-13 13:00	RNS	Notice of Results	Advance Notice of Results
10-May-13 16:28	RNS	Holding(s) in Company	Holding(s) in Company
10-May-13 16:24	RNS	Holding(s) in Company	Holding(s) in Company
09-May-13 15:40	RNS	Total Voting Rights	Holding(s) in Company
08-May-13 08:00	RNS	Closing of Initial Public Offering on Nasdaq	Company Announcement - General
07-May-13 07:00	RNS	Sativex Commercialization Approval in Italy	Company Announcement - General
01-May-13 17:47	RNS	Pricing of U.S. Initial Public Offering	Company Announcement - General
22-Apr-13 07:00	RNS	US Patent Allowance for SATIVEX Formulation Spray	Company Announcement - General
18-Apr-13 14:23	RNS	Amendment to Registration Statement for NASDAQ	Company Announcement - General
12-Apr-13 10:31	RNS	Results of General Meeting	Results and Trading Reports
10-Apr-13 07:00	RNS	Sativex moved to Schedule 4 of UK Drugs Act	Company Announcement - General
03-Apr-13 07:00	RNS	New US Patent Allowance for Delivery of SATIVEX	Company Announcement - General
22-Mar-13 14:35	RNS	Posting of Shareholder Circular	Company Announcement - General
19-Mar-13 14:46	RNS-R	Appoints Stephen Schultz VP of Investor Relations	Company Announcement - General
19-Mar-13 13:10	RNS	Update on Sativex in Germany	Company Announcement - General
19-Mar-13 13:01	RNS	Filing for listing on NASDAQ	Company Announcement - General
19-Feb-13 15:16	RNS	Directorate Change	Executive Changes
19-Feb-13 09:30	RNS	Blocklisting Interim Review	Company Announcement - General
21-Jan-13 11:44	RNS	Result of AGM	Results and Trading Reports
04-Dec-12 10:04	RNS	Director/PDMR Shareholding	Directors' Dealings
30-Nov-12 14:54	RNS	Director/PDMR Shareholding	Directors' Dealings
30-Nov-12 14:50	RNS	Director/PDMR Shareholding	Directors' Dealings
28-Nov-12 07:00	RNS	PhIIa Study Identifies New Anti-Diabetic Treatment	Company Announcement - General
28-Nov-12 07:00	RNS	Preliminary Results	Results and Trading Reports
22-Nov-12 11:31	RNS	Notice of Results	Advance Notice of Results
12-Oct-12 07:00	RNS-R	Positive German Sativex Data Presented at ECTRIMS	Company Announcement - General
01-Oct-12 07:00	RNS	Appointment of Chief Operating Officer	Company Announcement - General
13-Sep-12 07:00	RNS	Publication of New Epilepsy Data	Company Announcement - General
20-Aug-12 12:14	RNS	Director/PDMR Shareholding	Directors' Dealings
17-Aug-12 16:04	RNS	Blocklisting Interim Review	Company Announcement - General

Regulatory news is displayed end of day, each day at 19:00.

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.